Disturbance in tRNA production and/or translation to proteins due to a reduction in wild-type IGHMBP2 appears to be critical for the pathogenesis of SMARD1 or CMT2S. Here, IGHMBP2 is linked to Charcot-Marie-Tooth disease axonal type 2S.